Quarterly report pursuant to Section 13 or 15(d)

Shareholders' Deficit (Tables)

v3.21.1
Shareholders' Deficit (Tables)
 3 Months Ended
Mar. 31, 2021
Stockholders' Equity Note [Abstract]  
Schedule of activity related to non-vested shares
    Number of
Non-vested
Shares		     Weighted
Average
Grant Date
Fair Value		  
Non-vested, December 31, 2020     23,826,926     $ 0.16  
Granted     5,194,767       0.07  
Shares vested     (7,993,140 )     (0.12 )
Non-vested, March 31, 2021     21,028,553     $ 0.16  
Schedule of stock option activities
      Number of Options     Weighted Average
Exercise Price 		    Weighted
Average
Remaining
Contractual
Term (Years) 		    Aggregate
Intrinsic Value 		 
Balance Outstanding, December 31, 2020       8,445,698     $ 0.40       5.10      $  48,000   
Granted       -       -       -        -   
Forfeited       -       -       -        -   
Balance Outstanding, March 31, 2021       8,445,698     $ 0.40       4.92     $ 17,400  
Exercisable, March 31, 2021       8,445,698     $ 0.40       4.92     $ 17,400  
Schedule of warrant activities
      Number of Warrants     Weighted Average
Exercise Price 		    Weighted
Average
Remaining
Contractual
Term (Years) 		    Aggregate
Intrinsic Value 		 
Balance Outstanding December 31, 2020       2,050,000     $ 0.05       3.66     $ 137,000  
Exercised       (1,050,000 )      0.01       -        -   
Cancelled       -       -       -        -   
Balance Outstanding March 31, 2021       1,000,000     $ 0.09       3.31     $ 1,800  
Exercisable, March 31, 2021       1,000,000     $ 0.09       3.31     $ 1,800